Automatic double-check monitoring of continuous fluid excretion and urine output.
A peer-reviewed study describing the dual sensing principle behind Diuricheck and its validation across the full clinical flow range.
View publicationIn today's intensive care unit, every major vital sign is monitored electronically — except urine output. Diuriflux is changing that with a Swiss-made automated system for continuous, dual-sensing measurement at the bedside.
Measurement of fluid flow is crucial in physiologic studies and in clinical situations. Yet in today's intensive care unit, every major vital sign is tracked by a connected device — except urine output, which is still collected in a bag and transcribed by a nurse, hour after hour.
"The only parameter not measured automatically in hospital is urine output." — Diuriflux founders
Diuricheck is a compact bedside device with a central display, capturing both the total volume and the hourly flow of urine output — automatically, with two independent sensing technologies working in parallel.
Diuricheck slots into the existing urinary catheter circuit. No catheter change, no new procedure, no retraining. The device sits on the bed frame, where the bag used to hang.
A precision weighing chamber (dynamometric sensing) and a dielectric fluid-level sensor (capacitive sensing) work in parallel. Two independent measurements, reconciled in real time — for a higher level of reliability.
The bedside unit links wirelessly to a central monitor and integrates with the hospital information system via the HL7 standard. Volume, hourly flow, alerts — wherever the team is looking.
Bedside installation
Two independent measurement principles, cross-checked in real time. Unique in the segment.
Captures the two parameters clinicians actually use to assess renal function and fluid balance.
Secure wireless link to a central monitor. Native integration into hospital information systems.
Designed to slot into existing ICU practice without adding procedural complexity. Automation where it helps.
Our work has been the subject of a peer-reviewed publication, and the core architecture is covered by a patent family. More material is available to qualified partners on request.
A peer-reviewed study describing the dual sensing principle behind Diuricheck and its validation across the full clinical flow range.
View publication
The Diuricheck architecture is covered by a patent family. The foundational European application was published in 2020 and protects the core dual-sensing design.
View patentThe dual-sensing architecture has been validated under controlled bench conditions, including the critical low-flow regime where single-principle systems have historically been most fragile.
Diuriflux is a pure Swiss company, founded by two cardiology doctors — one of whom is also active in intensive care. In their daily practice, they noticed the one gap that connected monitoring had left untouched: urine output.
From that observation came a simple conviction: the measurement needed to be automated, reliable, and connected . The team assembled the engineering and clinical expertise to build it, and Diuricheck is the result.
The company is Swiss-based. The engineering is Swiss. The clinical rationale is grounded in intensive-care reality.
Clinicians, hospital networks, industrial partners, investors — if Diuricheck is relevant to a conversation you're having, drop us a line. We reply to every message.